The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study

The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study

Abstract Background Recently, side effects from Dopamine Receptor Agonist Drugs (DAs) in treating pituitary prolactinoma have raised widespread concern. This study explores the incidence and influencing factors of DAs-related side effects in Chinese prolactinoma patients. Methods A cross-sectional s...

Full description

Bibliographic Details
Main Authors: Xiaoan Ke, Linjie Wang, Meiping Chen, Shanshan Liu, Na Yu, Lian Duan, Fengying Gong, Huijuan Zhu
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Endocrine Disorders
Subjects:
Prolactinoma
Dopamine receptor agonist drugs (DAs)
Side effects
Impulse control disorders (ICDs)
Online Access:https://doi.org/10.1186/s12902-022-01009-3

Internet

https://doi.org/10.1186/s12902-022-01009-3

Similar Items